Search Results

Challenging Mechanical Thrombectomy to Manage an Internal Carotid Artery–T Occlusion

Moderator: Ajit S. Puri, MD;
Panelists: Muhammad Shazam Hussain, MD, FRCP(C); Peter T. Kan, MD; and Katyucia de Macedo Rodrigues, MD

Exploring the Why: Pivotal Case-Based Decisions

By Leigh Ann O’Banion, MD

Next Horizons: Interventional Neuro-Oncology

A look at the expanding role of interventional oncology for central nervous system and head and neck cancers.

By Stephen Chen, MD, and Peter Kan, MD, MPH, FRCSC, FAANS

Myocardial Infarction After CAS and CEA: Why Does It Matter?

Clinical or subclinical MI predicts mortality after carotid intervention and should be included in the primary endpoint composite of carotid trials.

By Peter Kan, MD, MPH; Travis M. Dumont, MD; Adib A. Anla, MD; Adnan H. Siddiqui, MD, PhD; Elad I. Levy, MD; and L. Nelson Hopkins, MD

Cerebral Flow Diverters and Disruptors in 2021: Where Do We Stand?

Key advancements, new devices, landmark trials, treatment strategies by aneurysm type, location, and clinical content, and future directions.

With Bree Chancellor, MD, MBA, and Peter K. Nelson, MD

Essential Innovation and Clinical Trial Needs in Vascular Care

Experts from a variety of specialty backgrounds comment on hurdles and opportunities for future clinical trials to explore.

With Kendal M. Endicott, MD; Jessica P. Simons, MD, MPH; Abinaya Ramakrishnan, BA; Salma Youssef; Mona Ranade, MD; John M. Moriarty, MD, FSIR; Peter A. Schneider, MD; Amy C. Taylor, MD; Sarah B. White, MD, MS, FSIR, FCIRSE; Stephen A. Black, MD, FRCS(Ed), FEBVS; Kunal P. Raygor, MD; Mehdi Bouslama, MD, MSc; and Elad I. Levy, MD, MBA

The Advent of Flow Diversion and Its Implications for Cerebral Aneurysm Treatment

A discussion of the principles of flow diversion and current use of flow diversion devices by location and type of aneurysm.

By Matthew J. Koch, MD; Christopher J. Stapleton, MD; Brian P. Walcott, MD; Scott B. Raymond, MD, PhD; and Aman B. Patel, MD